200 related articles for article (PubMed ID: 33495568)
41. Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration.
Hanumunthadu D; Saleh A; Florea D; Balaskas K; Keane PA; Aslam T; Patel PJ
BMC Ophthalmol; 2023 Feb; 23(1):68. PubMed ID: 36782163
[TBL] [Abstract][Full Text] [Related]
42. Volume Rendering of Deep Retinal Age-Related Microvascular Anomalies.
Cabral D; Ramtohul P; Fradinho AC; Freund KB
Ophthalmol Retina; 2022 Dec; 6(12):1185-1193. PubMed ID: 35772694
[TBL] [Abstract][Full Text] [Related]
43. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
[TBL] [Abstract][Full Text] [Related]
44. DETECTION OF TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION BY SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Ahmed D; Stattin M; Graf A; Forster J; Glittenberg C; Krebs I; Ansari-Shahrezaei S
Retina; 2018 Nov; 38(11):2143-2149. PubMed ID: 28902095
[TBL] [Abstract][Full Text] [Related]
45. Quantitative Optical Coherence Tomography Detection of New Neovascular Branches and Association With Exudation Recurrence in Neovascular Age-Related Macular Degeneration.
Arrigo A; Aragona E; Del Fabbro S; Balduzzi E; Parodi MB; Bandello F
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):30. PubMed ID: 38899961
[TBL] [Abstract][Full Text] [Related]
46. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
[TBL] [Abstract][Full Text] [Related]
47. Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration.
Roisman L; Zhang Q; Wang RK; Gregori G; Zhang A; Chen CL; Durbin MK; An L; Stetson PF; Robbins G; Miller A; Zheng F; Rosenfeld PJ
Ophthalmology; 2016 Jun; 123(6):1309-19. PubMed ID: 26876696
[TBL] [Abstract][Full Text] [Related]
48. Acute Central Serous Chorioretinopathy Subtypes as Assessed by Multimodal Imaging.
Arrigo A; Aragona E; Bordato A; Calamuneri A; Moretti AG; Mercuri S; Bandello F; Parodi MB
Transl Vis Sci Technol; 2021 Nov; 10(13):6. PubMed ID: 34739039
[TBL] [Abstract][Full Text] [Related]
49. Optical coherence tomography angiography in best vitelliform macular dystrophy.
Mirshahi A; Lashay A; Masoumi A; Abrishami M
J Curr Ophthalmol; 2019 Dec; 31(4):442-445. PubMed ID: 31844798
[TBL] [Abstract][Full Text] [Related]
50. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
Yang J; Zhang Q; Motulsky EH; Thulliez M; Shi Y; Lyu C; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
Am J Ophthalmol; 2019 Dec; 208():1-11. PubMed ID: 31229464
[TBL] [Abstract][Full Text] [Related]
51. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
Lyu Y; Li X; Gong Y
Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
[TBL] [Abstract][Full Text] [Related]
52. Clinical features associated with the atrophy of fellow eyes in patients with unilateral type 3 macular neovascularization.
Choi M; Yoon EG; Nam KT; Yun C
Int Ophthalmol; 2023 Mar; 43(3):973-980. PubMed ID: 36057916
[TBL] [Abstract][Full Text] [Related]
53. Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography.
Sulzbacher F; Pollreisz A; Kaider A; Kickinger S; Sacu S; Schmidt-Erfurth U;
Acta Ophthalmol; 2017 Jun; 95(4):414-420. PubMed ID: 28133946
[TBL] [Abstract][Full Text] [Related]
54. Anatomic Localization of Type 1 and Type 2 Macular Neovascularization Using Swept-Source OCT Angiography.
Motulsky EH; Zheng F; Shi Y; Gregori G; Rosenfeld PJ
Ophthalmic Surg Lasers Imaging Retina; 2018 Nov; 49(11):878-886. PubMed ID: 30457647
[TBL] [Abstract][Full Text] [Related]
55. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY.
Battaglia Parodi M; Iacono P; Romano F; Bandello F
Retina; 2018 May; 38(5):1041-1046. PubMed ID: 28376040
[TBL] [Abstract][Full Text] [Related]
56. Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development.
Sacconi R; Sarraf D; Sadda SR; Freund KB; Servillo A; Fogel Levin MM; Costanzo E; Corradetti G; Cabral D; Zur D; Trivizki O; Parravano M; Bandello F; Loewenstein A; Querques G
Ophthalmol Retina; 2023 Jul; 7(7):586-592. PubMed ID: 36736896
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography.
Waldstein SM; Vogl WD; Bogunovic H; Sadeghipour A; Riedl S; Schmidt-Erfurth U
JAMA Ophthalmol; 2020 Jul; 138(7):740-747. PubMed ID: 32379287
[TBL] [Abstract][Full Text] [Related]
58. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
59. OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti-Vascular Endothelial Growth Factor Therapy.
Farinha C; Santos T; Santos AR; Lopes M; Alves D; Silva R; Cunha-Vaz J
Retina; 2020 May; 40(5):881-890. PubMed ID: 30689620
[TBL] [Abstract][Full Text] [Related]
60. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
